Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06752577 · ClinicalTrials.gov registry record
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
A clinical trial of Chronic Kidney Diseases and Kidney Transplant, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT06752577 is a study of Chronic Kidney Diseases and Kidney Transplant that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 75 participants, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06752577, a study of Chronic Kidney Diseases and Kidney Transplant, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this protocol is to treat an intermediate-sized population with chronic kidney disease (CKD) including kidney transplant recipients. The protocol uses allogeneic bone marrow-derived mesenchymal stem cells (MSCs). MSC infusion may be delivered 1) intravenous or 2) intravenous plus intra-arterial to both kidneys. Individuals will have subsequent follow up for safety evaluations. Repeat dosing is allowed.
Conditions Studied
Interventions
- DRUG Allogeneic, vertebral bone marrow-derived mesenchymal stem cells (MSC)
Study Locations (1)
Florida
- Mayo Clinic - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2024-12-22 |
| Est. Completion | 2031-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06752577
The ClinicalTrials.gov registry entry for NCT06752577 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (83% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which Allogeneic, vertebral bone marrow-derived mesenchymal stem cells (MSC) is the first listed.
NCT06752577 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06752577 about?
NCT06752577 is a clinical study titled "Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)". The purpose of this protocol is to treat an intermediate-sized population with chronic kidney disease (CKD) including kidney transplant recipients. The protocol uses allogeneic bone marrow-derived mesenchymal stem cells (MSCs). MSC infusion may be delivered 1) intravenous or 2) intravenous plus intr...
What is the current status of trial NCT06752577?
This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2024-12-22. Estimated completion is 2031-12-31.
What conditions does trial NCT06752577 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases, Kidney Transplant.
What interventions are being tested in trial NCT06752577?
The interventions under investigation include: Allogeneic, vertebral bone marrow-derived mesenchymal stem cells (MSC) (DRUG).
Who is sponsoring clinical trial NCT06752577?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06752577 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
RECRUITING · Phase 2
-
Mindfulness in Chronic Kidney Disease
RECRUITING · NA
-
Ferric Citrate and Chronic Kidney Disease in Children
RECRUITING · Phase 2
-
A Long-Term Follow-Up Study of Participants Exposed to REACT
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.